Minnesota Oncology
Latest Clinical News

In Advanced Pancreatic Cancer, Eloxatin® with Folinic Acid and Fluorouracil May Improve Survival (07-10-2014)

In a Phase III study, the addition of the chemotherapy drug Eloxatin® (oxaliplatin) to the chemotherapy regimen of folinic acid and fluorouracil (5-FU) improved outcomes in patients with advanced pancreatic cancer that had progressed on Gemzar® (gemcitabine).... Continue Reading

TAS-102 Improves Survival in Advanced Colorectal Cancer (07-9-2014)

Researchers recently reported that the new combination agent TAS-102 improves overall survival in patients whose metastatic colorectal cancer is refractory to standard therapies. These results were recently reported at the ESMO 16th World Congress on... Continue Reading

Trial Evaluating Nivolumab in Advanced Melanoma Halted Early Because of Superior Results (07-8-2014)

Bristol-Myers Squibb announced on Tuesday that its clinical trial evaluating cancer immunotherapy nivolumab, which is being developed in advanced melanoma was halted early after it was determined that the drug was likely to prolong survival. Nivolumab... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (07-7-2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive axillary sentinel... Continue Reading

More Effective Colorectal Cancer Prevention with Colonoscopy Doctor with High Rate of Polyp Detection (07-3-2014)

Recent findings suggest that for more effective colorectal cancer prevention, it’s best to choose a physician for colonoscopy with a higher rate of precancerous polyp detection; meaning that he or she detects more polyps than colleagues in proportion... Continue Reading

Study Shows Polypectomy as Effective as Partial Colon Resection (07-2-2014)

A team from Stony Brook University reported that patients requiring removal of colon polyps could be effectively treated with laparoscopic-assisted polypectomy (LACP) and that the procedure required fewer resources than did partial colon resection (laparoscopic... Continue Reading

Aspirin Reduces Risk of Pancreatic Cancer (07-1-2014)

The results of a recent study suggest that regular aspirin use reduces the risk of pancreatic cancer by half.  Clinical studies have also found that regular aspirin use can reduce the risk for colon, esophageal, lung and prostate cancers, as well as... Continue Reading

Updated Analysis of the MPACT Study in Advanced Pancreatic Cancer Demonstrates Continued Improvement in Survival for Abraxane-based Chemotherapy (07-1-2014)

A follow up report on the results of the Metastatic Pancreatic Adenocarcinoma Clinical Trial (MPACT) study of Abraxane® (nab-paclitaxel) in combination with Gemzar® (gemcitabine) in previously untreated patients with metastatic pancreatic cancer... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (06-30-2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex® (goserelin) had a reduced rate of ovarian failure... Continue Reading

Torisel Improves Event-Free Survival in Rhabdomyosarcoma Patients (06-27-2014)

In a study presented at the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that Torisel® (temsirolimus) added to a chemotherapy regimen improved event-free survival in young patients with rhabdomyosarcoma. Rhabdomyosarcoma... Continue Reading

Apatinib Prolongs Survival in Advanced Gastric Cancer (06-26-2014)

Apatinib significantly improved overall survival according to the results of a phase III study presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Gastric cancer refers to cancer of the stomach. Though gastric... Continue Reading

Aromasin Reduces Risk of Recurrence in Early Breast Cancer (06-25-2014)

In a joint analysis of two clinical trials reported at the American Society of Clinical Oncologists meeting in Chicago, researchers found that premenopausal women undergoing hormone suppression and who were treated with Aromasin® (exemestane) had reduced... Continue Reading

Next Page »